The Innovations Symposium brings together forward-thinking researchers, clinicians, and industry professionals who are working to solve Inflammatory Bowel Disease (IBD). Hear a range of perspectives from leaders working within and outside of the IBD field.
Registration has ended.
Yasmine Belkaid, PhD
Chief, National Institute of Allergy and Infectious DiseasesSpeaker Highlights The Belkaid lab aims to understand the mechanisms controlling host microbe interactions at barrier sites such as the skin and the gut. These two sites represent the first portal of pathogen exposure and are major anatomical sites for development of inflammatory disorders. Learn more
Julie Magarian Blander, PhD
Professor, Weill Cornell MedicineSpeaker Highlights The Blander lab studies the fundamental principles of innate immunity and inflammation and their application to human disease. Their research is on the functions of phagocytes in infection, cancer, and chronic inflammation, with the goal to create treatments and vaccines against disease. Learn more
Meghan Koch, PhD
Assistant Professor, Fred Hutch Cancer CenterSpeaker Highlights The Koch lab studies maternal-fetal interactions, focusing on immunity, metabolism and the microbiota. They’ve shown that maternal antibodies transmitted from mother to offspring ‘instruct’ mucosal immune responses in neonates and are expanding on those findings to try to identify novel pathways through which maternal-offspring interactions regulate neonatal health. Learn more.
Richard Locksley, MD
Professor, University of California, San FranciscoSpeaker Highlights Dr. Locksley’s lab addresses the immune cells and tissue responses that occur during allergic, or type 2, immunity. The laboratory increasingly focuses on innate immunity, particularly since the discovery of Group 2 innate lymphoid cells, or ILC2s, which are prominently involved in allergy. Learn more
Sarkis Mazmanian, PhD
Professor, California Institute of TechnologySpeaker Highlights The Mazmanian lab has demonstrated that intestinal bacteria direct development and function of the immune system in the gut and brain, and control complex behaviors in animal models; thus fundamental aspects of health are inextricably dependent on the microbiome. Learn more
Daniel Mucida, PhD
Professor, Rockefeller UniversitySpeaker Highlights The Mucida lab studies how the intestine generates protective responses against invading pathogens (resistance) while absorbing beneficial microbe– and food–derived molecules (tolerance). Learn more
Julie Pfeiffer, PhD
Professor, University of Texas Southwestern Medical CenterSpeaker Highlights The Pfeiffer lab uses tractable model viruses to learn about niche-specific factors that influence viral infection and evolution. Learn more
Fiona Powrie, PhD
Professor and Director of the Kennedy Institute, University of OxfordSpeaker Highlights The Powrie lab employs basic and translational science to study host-microbe crosstalk in health and disease, focusing on inflammatory bowel disease (IBD), colorectal cancer (CRC) and inflammatory arthritis. Learn more
June Round, PhD
Professor, University of Utah School of MedicineSpeaker Highlights The Round lab explores causal associations between gut microbes and health. We analyze a diverse array of microbes including bacteriophages, fungi and bacteria to uncover the mechanistic underpinnings of how these organisms influence disease. Learn more
Tiffany Scharschmidt, MD
Associate Professor, University of California, San FranciscoSpeaker Highlights The Scharschmidt lab investigates the cellular and molecular mechanisms that mediate interactions between bacteria and the developing immune system, with a long-term goal of developing new therapeutic approaches. Learn more
David Suskind, MD
Professor, University of Washington School of MedicineSpeaker Highlights Dr. Suskind’s research focuses on the effect of fecal microbial transformation and diet on IBD. He has conducted studies on the clinical, laboratory, and microbiome changes that occur after FMT and on the transformative impact nutritional interventions have on patients with IBD. Learn more